Current Trends of Targeted Drug Delivery for Oral Cancer Therapy

被引:68
作者
Zhang, Mingming [1 ]
Liang, Jianqin [2 ]
Yang, Yanyu [3 ]
Liang, Huize [1 ]
Jia, Huaping [1 ]
Li, Dawei [4 ]
机构
[1] Strateg Support Force Characterist Med Ctr Chines, Beijing, Peoples R China
[2] Gen Hosp Chinese Peoples Liberat Army, Med Ctr 8, Beijing, Peoples R China
[3] Zhengzhou Univ, Coll Mat Sci & Engn, Zhengzhou, Peoples R China
[4] Gen Hosp Chinese Peoples Liberat Army, Med Ctr 4, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
oral cancer; drug delivery; nanoparticles; nanotechnology; OSCC (oral squamous cell carcinoma); SQUAMOUS-CELL CARCINOMA; NANOPARTICLES; HYDROGELS; HEAD; CARRIERS; SYSTEMS; EXOSOMES; GENE; NANOCARRIERS; CHEMOTHERAPY;
D O I
10.3389/fbioe.2020.618931
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Oral cancer is an aggressive tumor that invades the local tissue and can cause metastasis and high mortality. Conventional treatment strategies, e.g., surgery, chemotherapy, and radiation therapy alone or in combinations, possess innegligible issues, and significant side and adverse effects for the clinical applications. Currently, targeting drug delivery is emerging as an effective approach for oral delivery of different therapeutics. Herein we provide a state-of-the-art review on the current progress of targeting drug delivery for oral cancer therapy. Variously oral delivery systems including polymeric/inorganic nanoparticles, liposomes, cyclodextrins, nanolipids, and hydrogels-based forms are emphasized and discussed, and biomimetic systems with respect to oral delivery like therapeutic vitamin, exosomes, proteins, and virus-like particles are also described with emphasis on the cancer treatment. A future perspective is also provided to highlight the existing challenges and possible resolution toward clinical translation of current oral cancer therapies.
引用
收藏
页数:11
相关论文
共 87 条
[1]   Systems Biology Approaches and Precision Oral Health: A Circadian Clock Perspective [J].
Adeola, Henry A. ;
Papagerakis, Silvana ;
Papagerakis, Petros .
FRONTIERS IN PHYSIOLOGY, 2019, 10
[2]   Combined hydroxypropyl-β-cyclodextrin and poly(anhydride) nanoparticles improve the oral permeability of paclitaxel [J].
Agueeros, M. ;
Ruiz-Gaton, L. ;
Vauthier, C. ;
Bouchemal, K. ;
Espuelas, S. ;
Ponchel, G. ;
Irache, J. M. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2009, 38 (04) :405-413
[3]  
[Anonymous], 2020, FRONT BIOENG BIOTECH
[4]  
[Anonymous], 2012, NANOPARTICULATE DRUG
[5]  
[Anonymous], 2017, J. Adv. Pharm. Educ. Res
[6]  
[Anonymous], 2020, FRONT CHEM
[7]  
[Anonymous], 2020, FRONT BIOENG BIOTECH
[8]   Fabrication of Customized Nanogel Carriers From a UV-Triggered Dynamic Self-Assembly Strategy [J].
Bao, Wuren ;
Lyu, Jieran ;
Li, Chunlin ;
Zhang, Jifeng ;
Sun, Tunan ;
Wang, Xing ;
Zhou, Jin ;
Li, Dawei .
FRONTIERS IN CHEMISTRY, 2019, 7
[9]   Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck [J].
Baselga, J ;
Trigo, JM ;
Bourhis, J ;
Tortochaux, J ;
Cortés-Funes, H ;
Hitt, R ;
Gascón, P ;
Arnellal, N ;
Harstrick, A ;
Eckardt, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5568-5577
[10]   Using exosomes, naturally-equipped nanocarriers, for drug delivery [J].
Batrakova, Elena V. ;
Kim, Myung Soo .
JOURNAL OF CONTROLLED RELEASE, 2015, 219 :396-405